Company’s 36-month beta value is 1.34.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for NNVC is 13.78M, and currently, short sellers hold a 1.04% ratio of that floaft. The average trading volume of NNVC on January 24, 2025 was 301.40K shares.
NNVC) stock’s latest price update
NanoViricides Inc (AMEX: NNVC) has experienced a decline in its stock price by -5.88 compared to its previous closing price of 1.19. However, the company has seen a fall of -6.67% in its stock price over the last five trading days. accesswire.com reported 2025-01-13 that SHELTON, CT / ACCESSWIRE / January 13, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced today that it is presenting at Biotech Showcase™ 2025 in San Fransisco, being held in parallel to the JP Morgan Life Sciences Conference. Event Information: Event NanoViricides Presentation at the Biotech Showcase, San Fransisco Day & Date Tuesday, January 14, 2025 Time, Track & Room 2:30pm PT, Yosemite A (Ballroom Level) Location Hilton San Fransisco – Union Square Anil R.
NNVC’s Market Performance
NanoViricides Inc (NNVC) has seen a -6.67% fall in stock performance for the week, with a -22.76% decline in the past month and a -23.81% plunge in the past quarter. The volatility ratio for the week is 6.40%, and the volatility levels for the past 30 days are at 7.59% for NNVC. The simple moving average for the past 20 days is -17.59% for NNVC’s stock, with a -33.04% simple moving average for the past 200 days.
Analysts’ Opinion of NNVC
Many brokerage firms have already submitted their reports for NNVC stocks, with Midtown Partners repeating the rating for NNVC by listing it as a “Strong Buy.” The predicted price for NNVC in the upcoming period, according to Midtown Partners is $5.30 based on the research report published on February 11, 2015 of the previous year 2015.
NNVC Trading at -19.24% from the 50-Day Moving Average
After a stumble in the market that brought NNVC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -68.80% of loss for the given period.
Volatility was left at 7.59%, however, over the last 30 days, the volatility rate increased by 6.40%, as shares sank -24.83% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -24.83% lower at present.
During the last 5 trading sessions, NNVC fell by -6.67%, which changed the moving average for the period of 200-days by -18.25% in comparison to the 20-day moving average, which settled at $1.3590. In addition, NanoViricides Inc saw -21.68% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NNVC
The total capital return value is set at -0.95. Equity return is now at value -81.92, with -69.61 for asset returns.
Currently, EBITDA for the company is -7.76 million with net debt to EBITDA at 0.44. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.48.
Conclusion
In a nutshell, NanoViricides Inc (NNVC) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
